Posted by Christ_empowered on November 1, 2011, at 6:30:30
In reply to Re: Reboxetine, posted by rculater on November 1, 2011, at 4:54:16
Its kind of unfortunate that the SSRIs hit it big and clogged the market with me-too drugs. Kind of strange for someone to be termed "treatment-resistant" for failing on drugs that, as a group, often fail to outperform placebo. Of course, this is psychiatry, so the problem lies with the patient.
Anyway, these newer drugs seem interesting, although I kind of question mixing and matching reuptake inhibitors. Didn't the STAR*D trial, or whatever its called, show a really unimpressive response rate to multiple ADs? Of course, I'm sure it works in some patients, but it seems like the practice has been extended to most patients who demonstrate "treatment-resistance," just from what I've seen on here and heard from my acquaintances.
poster:Christ_empowered
thread:1001353
URL: http://www.dr-bob.org/babble/20111027/msgs/1001422.html